Molecular Targets in Protein Misfolding and Neurodegenerative Disease

Aimed at "drug discoverers" – i.

e.

any scientist who is interested in neurodegenerative diseases in general, and in finding disease-modifying treatments in particular – the first edition of Molecular Targets in Protein Misfolding and Neurodegenerative Disease will contain both a detailed, discipline-specific coverage (paragraphs on medicinal chemistry, on clinical and preclinical characterization of compounds in development, on target identification and validation, on genetic factors influencing a pathology, etc.

) and a drug discovery-oriented, overall evaluation of each target (validation, druggability, existing leads, etc.

).

Together these will satisfy the needs of various audiences, including in vitro biologists, pharmacologists, medicinal chemists, etc.